SCINTIGRAPHIC AND PHARMACOKINETIC ASSESSMENT OF A MULTIPARTICULATE SUSTAINED-RELEASE FORMULATION OF DILTIAZEM

被引:26
作者
WILDING, IR
HARDY, JG
MACCARI, M
RAVELLI, V
DAVIS, SS
机构
[1] PHARMATEC INT,I-20090 TREZZANO,ITALY
[2] UNIV NOTTINGHAM,DEPT PHARMACEUT SCI,NOTTINGHAM NG7 2RD,ENGLAND
关键词
DILTIAZEM; GAMMA SCINTIGRAPHY; ABSORPTION; PELLET; GASTROINTESTINAL TRANSIT; SUSTAINED RELEASE;
D O I
10.1016/0378-5173(91)90351-N
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The in vivo behaviour of a sustained release multiparticulate form of diltiazem (240 mg) has been evaluated by gamma scintigraphy in eight subjects under fasting or fed conditions. The gastric emptying of the pellet formulation was significantly influenced by the presence of food. Transit through the small intestine was unaffected by food and in the majority of cases, the formulation reached the caecum about 3-4 h after leaving the stomach. Post-prandial administration of the sustained release pellet formulation did not affect the bioavailability of the drug. The type of oral formulation (i.e. solution or pellets) appeared to affect the rate, but not the extent, of absorption with the relative bioavailability (pellets to solution) being greater than 90%.
引用
收藏
页码:133 / 143
页数:11
相关论文
共 50 条
[31]   Pharmacokinetic Studies of Sustained-Release Depot of Dexamethasone in Beagle Dogs [J].
Blizzard, Charles ;
Desai, Ankita ;
Driscoll, Arthur .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2016, 32 (09) :595-600
[32]   PHARMACOKINETIC ANALYSIS OF 2 NEW SUSTAINED-RELEASE PRODUCTS OF DILTIAZEM DESIGNED FOR TWICE-DAILY AND ONCE-DAILY TREATMENT [J].
BIALER, M ;
HADAD, S ;
GOLOMB, G ;
BAREL, S ;
SAMARA, E ;
ABUSALACH, O ;
BERKMAN, N ;
DANENBERG, HD ;
BENDAVID, J ;
CARON, D ;
KAPLAN, R ;
TAMIR, A ;
FRIEDMAN, M .
BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (01) :45-52
[33]   THE EFFECT OF FOOD ON THE INVIVO BEHAVIOR OF A NOVEL SUSTAINED-RELEASE FORMULATION OF TIAPROFENIC ACID [J].
WILDING, IR ;
DAVIS, SS ;
SPARROW, RA ;
BLOOR, JR ;
HAYES, G ;
WARD, GT .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1992, 83 (1-3) :155-161
[34]   Sustained-release multiparticulates for oral delivery of a novel peptidic ghrelin agonist: Formulation design and in vitro characterization [J].
Howick, Ken ;
Alam, Ryan ;
Chruscicka, Barbara ;
Kandil, Dalia ;
Fitzpatrick, Dara ;
Ryan, Aoife M. ;
Cryan, John F. ;
Schellekens, Harriet ;
Griffin, Brendan T. .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2018, 536 (01) :63-72
[35]   Formulation and In vitro/In vivo Evaluation of Sustained Release Diltiazem Matrix Tablets [J].
Baviskar, Dheeraj ;
Sharma, Rajesh ;
Jain, Dinesh .
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2013, 12 (03) :311-316
[36]   Formulation and In vitro/In vivo Evaluation of Sustained Release Diltiazem Matrix Tablets [J].
Baviskar, Dheeraj ;
Sharma, Rajesh ;
Jain, Dinesh .
TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2013, 12 (05) :679-684
[37]   Formulation study and drug release mechanism of a new theophylline sustained-release preparation [J].
Hayashi, T ;
Kanbe, H ;
Okada, M ;
Suzuki, M ;
Ikeda, Y ;
Onuki, Y ;
Kaneko, T ;
Sonobe, T .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2005, 304 (1-2) :91-101
[38]   PREDICTIVE MODELING OF THE BEHAVIOR OF A CONTROLLED RELEASE BUFLOMEDIL HCL FORMULATION USING SCINTIGRAPHIC AND PHARMACOKINETIC DATA [J].
WILSON, CG ;
WASHINGTON, N ;
GREAVES, JL ;
WASHINGTON, C ;
WILDING, IR ;
HOADLEY, T ;
SIMS, EE .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1991, 72 (01) :79-86
[39]   Design of experiment (DoE)-based formulation design of bepotastine sustained-release tablet and in vitro-in vivo pharmacokinetic correlation [J].
Sang-Won Jeon ;
Jin-Hyun Park ;
Joo-Eun Kim ;
Young-Joon Park .
Journal of Pharmaceutical Investigation, 2023, 53 :407-416
[40]   Design of experiment (DoE)-based formulation design of bepotastine sustained-release tablet and in vitro-in vivo pharmacokinetic correlation [J].
Jeon, Sang-Won ;
Park, Jin-Hyun ;
Kim, Joo-Eun ;
Park, Young-Joon .
JOURNAL OF PHARMACEUTICAL INVESTIGATION, 2023, 53 (03) :407-416